Dyskeratosis congenita: A disorder of defective telomere maintenance?

International Journal of Hematology

Volumn 82, Issue 3, 2005, Pages 184-189

  Walne, Amanda J ^a   Marrone, Anna ^a   Dokal, Inderjeet ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Aplastic anemia; Dyskeratosis congenita; Dyskerin; Telomerase; TERC; TERT

Indexed keywords

DYSKERIN; GENE PRODUCT; RIBOSOME RNA; SMALL NUCLEOLAR RIBONUCLEOPROTEIN; TELOMERASE;

AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; BONE MARROW DEPRESSION; CANCER; CHEMICAL MODIFICATION; CLINICAL FEATURE; DKC1 GENE; DYSKERATOSIS CONGENITA; GENE; GENE MUTATION; HUMAN; PATHOLOGY; PREMATURE AGING; PSEUDOURIDYLATION; REVIEW; RNA PROCESSING; TELOMERE; TERC GENE; X CHROMOSOME LINKAGE;

CELL CYCLE PROTEINS; CHROMOSOMES, HUMAN, X; DYSKERATOSIS CONGENITA; HUMANS; NUCLEAR PROTEINS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, RIBOSOMAL; TELOMERASE; TELOMERE;

EID: 27644548532     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.05067     Document Type: Review

References (66)

1. Broccoli D. Function, replication and structure of the mammalian telomere. Cytotechnology. 2004;45:3-12.
2. Blackburn EH. The end of the (DNA) line. Nat Struct Biol. 2000;7:847-850.
3. Cong YS, Wright WE, Shay JW. Human telomerase and its regulation. Microbiol Mol Biol Rev. 2002;66:407-425.
4. De Lange T. Protection of mammalian telomeres. Oncogene. 2002;21:532-540.
5. Autexier C, Greider CW. Functional reconstitution of wild-type and mutant Tetrahymena telomerase. Genes Dev. 1994;8:563-575.
6. Pogacic V, Dragon F, Filipowicz W. Human H/ACA small nucleolar RNPs and telomerase share evolutionarily conserved proteins NHP2 and NOP10. Mol Cell Biol. 2000;20:9028-9040.
7. Dragon F, Pogacic V, Filipowicz W. In vitro assembly of human H/ACA small nucleolar RNPs reveals unique features of U17 and telomerase RNAs. Mol Cell Biol. 2000;20:3037-3048.
8. Karlseder J. Telomere repeat binding factors: keeping the ends in check. Cancer Lett.2003;194:189-197.
9. Masutomi K, Yu EY, Khurts S, et al. Telomerase maintains telomere structure in normal human cells. Cell. 2003;114:241-253.
10. Wong JM, Collins K. Telomere maintenance and disease. Lancet. 2003;362:983-988.
11. Colgin LM, Reddel RR. Telomere maintenance mechanisms and cellular immortalization. Curr Opin Genet Dev. 1999;9:97-103.
12. Broccoli D, Young JW, de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci U S A. 1995;92:9082-9086.
13. Chiu CP, Dragowska W, Kim NW, et al. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells. 1996;14:239-248.
14. Harle-Bachor C, Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci U S A. 1996;93:6476-6481.
15. Yasumoto S, Kunimura C, Kikuchi K, et al. Telomerase activity in normal human epithelial cells. Oncogene. 1996;13:433-439.
16. Zinsser F. Atropha cutis reticularis cum pigmentatione, dystrophia ungium et leukoplakia oris. Ikonogr Dermatol (Hyoto). 1906;5:219-223.
17. Engman MF. A unique case of reticular pigmentation of the skin with atrophy. Arch Dermatol Syph. 1926;13:685-687.
18. Cole HN, Rauschkolb JC, Toomey J. Dyskeratosis congenita with pigmentation, dystrophia unguis and leukokeratosis oris. Arch Dermatol Syph. 1930;21:71-95.
19. Sirinavin C, Trowbridge AA. Dyskeratosis congenita: clinical features and genetic aspects: report of a family and review of the literature. J Med Genet. 1975;12:339-354.
20. Drachtman RA, Alter BP. Dyskeratosis congenita. Dermatol Clin. 1995;13:33-39.
21. Knight S, Vulliamy T, Copplestone A, Gluckman E, Mason P, Dokal I. Dyskeratosis Congenita (DC) Registry: identification of new features of DC. Br J Haematol. 1998;103:990-996.
22. Dokal I. Dyskeratosis congenita in all its forms. Br J Haematol. 2000;110:768-779.
23. Heiss NS, Knight SW, Vulliamy TJ, et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet. 1998;19:32-38.
24. Vulliamy T, Marrone A, Goldman F, et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature. 2001;413:432-435.
25. Meier UT, Blobel G. NAP57, a mammalian nucleolar protein with a putative homolog in yeast and bacteria. J Cell Biol. 1994;127:1505-1514.
26. Tollervey D, Kiss T. Function and synthesis of small nucleolar RNAs. Curr Opin Cell Biol. 1997;9:337-342.
27. Filipowicz W, Pogacic V. Biogenesis of small nucleolar ribonucleoproteins. Curr Opin Cell Biol. 2002;14:319-327.
28. Lafontaine DL, Bousquet-Antonelli C, Henry Y, Caizergues-Ferrer M, Tollervey D. The box H+ACA snoRNAs carry Cbf5p, the putative rRNA pseudouridine synthase. Genes Dev. 1998;12:527-537.
29. Zebarjadian Y, King T, Fournier MJ, Clarke L, Carbon J. Point mutations in yeast CBF5 can abolish in vivo pseudouridylation of rRNA. Mol Cell Biol. 1999;19:7461-7472.
30. Henras A, Henry Y, Bousquet-Antonelli C, Noaillac-Depeyre J, Gelugne JP, Caizergues-Ferrer M. Nhp2p and Nop10p are essential for the function of H/ACA snoRNPs. EMBO J. 1998;17:7078-7090.
31. Henras AK, Capeyrou R, Henry Y, Caizergues-Ferrer M. Cbf5p, the putative pseudouridine synthase of H/ACA-type snoRNPs, can form a complex with Gar1p and Nop10p in absence of Nhp2p and box H/ACA snoRNAs. RNA. 2004;10:1704-1712.
32. Wang C, Meier UT. Architecture and assembly of mammalian H/ACA small nucleolar and telomerase ribonucleoproteins. EMBO J. 2004;23:1857-1867.
33. Meier UT. The many facets of H/ACA ribonucleoproteins. Chromosoma. 2005;114:1-14.
34. Luzzatto L, Karadimitris A. Dyskeratosis and ribosomal rebellion. Nat Genet. 1998;19:6-7.
35. Mitchell JR, Wood E, Collins K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature. 1999;402:551-555.
36. Mitchell JR, Cheng J, Collins K. A box H/ACA small nucleolar RNA-like domain at the human telomerase RNA 3′ end. Mol Cell Biol. 1999;19:567-576.
37. Vulliamy TJ, Knight SW, Mason PJ, Dokal I. Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cells Mol Dis. 2001;27:353-357.
38. Mochizuki Y, He J, Kulkarni S, Bessler M, Mason PJ. Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing. Proc Natl Acad Sci U S A. 2004;101:10756-10761.
39. Marrone A, Dokal I. Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer. Expert Rev Mol Med. 2004;6:1-23.
40. Kanegane H, Kasahara Y, Okamura J, et al. Identification of DKC1 gene mutations in Japanese patients with X-linked dyskeratosis congenita. Br J Haematol. 2005;129:432-434.
41. Knight SW, Heiss NS, Vulliamy TJ, et al. X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene. Am J Hum Genet. 1999;65:50-58.
42. Zucchini C, Strippoli P, Biolchi A, et al. The human TruB family of pseudouridine synthase genes, including the Dyskeratosis Congenita 1 gene and the novel member TRUB1. Int J Mol Med. 2003;11:697-704.
43. Ramamurthy V, Swann SL, Paulson JL, Spedaliere CJ, Mueller EG. Critical aspartic acid residues in pseudouridine synthases. J Biol Chem. 1999;274:22225-22230.
44. Knight SW, Vulliamy TJ, Morgan B, Devriendt K, Mason PJ, Dokal I. Identification of novel DKC1 mutations in patients with dyskeratosis congenita: implications for pathophysiology and diagnosis. Hum Genet. 2001;108:299-303.
45. Fu D, Collins K. Distinct biogenesis pathways for human telomerase RNA and H/ACA small nucleolar RNAs. Mol Cell. 2003;11:1361-1372.
46. Ren X, Gavory G, Li H, Ying L, Klenerman D, Balasubramanian S. Identification of a new RNA-RNA interaction site for human telomerase RNA (hTR): structural implications for hTR accumulation and a dyskeratosis congenita point mutation. Nucleic Acids Res. 2003;31:6509-6515.
47. Ueda CT, Roberts RW. Analysis of a long-range interaction between conserved domains of human telomerase RNA. RNA. 2004;10:139-147.
48. Keppler BR, Jarstfer MB. Inhibition of telomerase activity by preventing proper assemblage. Biochemistry. 2004;43:334-343.
49. Marrone A, Stevens D, Vulliamy T, Dokal I, Mason PJ. Heterozygous telomerase RNA mutations found in dyskeratosis congenita and aplastic anemia reduce telomerase activity via haploinsufficiency. Blood. 2004;104:3936-3942.
50. Cerone MA, Ward RJ, Londono-Vallejo JA, Autexier C. Telomerase RNA mutated in autosomal dyskeratosis congenita reconstitutes a weakly active telomerase enzyme defective in telomere elongation. Cell Cycle. 2005;4:585-589.
51. Yeo M, Rha SY, Jeung HC, et al. Different role of functional domains of hTR in DNA binding to telomere and telomerase reconstruction. FEBS Lett. 2005;579:127-132.
52. Yingling YG, Shapiro BA. Dynamic behaviour of the telomerase RNA hairpin structure and its relationship to dyskeratosis congenita. J Mol Biol. 2005;348:27-42.
53. Vulliamy T, Marrone A, Szydlo R, Walne A, Mason PJ, Dokal I. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat Genet. 2004;36:447-449.
54. Shay JW, Wright WE. Telomeres in dyskeratosis congenita. Nat Genet. 2004;36:437-438.
55. Ball SE, Gibson FM, Rizzo S, Tooze JA, Marsh JC, Gordon-Smith EC. Progressive telomere shortening in aplastic anemia. Blood. 1998;91:3582-3592.
56. Brummendorf TH, Maciejewski JP, Mak J, Young NS, Lansdorp PM. Telomere length in leukocyte subpopulations of patients with aplastic anemia. Blood. 2001;97:895-900.
57. + hematopoiesis. Blood. 2003;102:514-516.
58. Vulliamy T, Marrone A, Dokal I, Mason PJ. Association between aplastic anaemia and mutations in telomerase RNA. Lancet. 2002;359:2168-2170.
59. Fogarty PF, Yamaguchi H, Wiestner A, et al. Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA. Lancet. 2003;362:1628-1630.
60. Yamaguchi H, Baerlocher GM, Lansdorp PM, et al. Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome. Blood. 2003;102:916-918.
61. Keith WN, Vulliamy T, Zhao J, et al. A mutation in a functional Sp1 binding site of the telomerase RNA gene (hTERC) promoter in a patient with paroxysmal nocturnal haemoglobinuria. BMC Blood Disord. 2004;4:3.
62. Knight SW, Heiss NS, Vulliamy TJ, et al. Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1. Br J Haematol. 1999;107:335-339.
63. Yaghmai R, Kimyai-Asadi A, Rostamiani K, et al. Overlap of dyskeratosis congenita with the Hoyeraal-Hreidarsson syndrome. J Pediatr. 2000;136:390-393.
64. Vulliamy TJ, Walne A, Baskaradas A, Mason PJ, Marrone A, Dokal I. Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure. Blood Cells Mol Dis. 2005;34:257-263.
65. Yamaguchi H, Calado RT, Ly H, et al. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N Engl J Med. 2005;352:1413-1424.
66. Holt SE, Aisner DL, Baur J, et al. Functional requirement of p23 and Hsp90 in telomerase complexes. Genes Dev. 1999;13:817-826.